Filing Analysis
Regulation FD Disclosure
Filed May 04, 2026
LOW
Biodesix, Inc. announced its financial and operating results for the first quarter ended March 31, 2026, via a press release. The filing serves as a standard quarterly earnings disclosure under Item 2.02.
Key Facts
- The report was filed on May 4, 2026, covering the fiscal quarter ended March 31, 2026.
- The financial results were disclosed through a press release furnished as Exhibit 99.1.
- The information in the filing is furnished under Item 2.02 and is not deemed 'filed' for Section 18 purposes.
Regulation FD Disclosure
Filed Feb 26, 2026
LOW
Biodesix, Inc. announced its financial and operating results for the fourth quarter and fiscal year ended December 31, 2025. The announcement was made via a press release furnished with the filing.
Key Facts
- Announced Q4 and full year 2025 financial results on February 26, 2026.
- The filing includes Item 2.02 (Results of Operations and Financial Condition).
- A press release was furnished as Exhibit 99.1.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.